Mustea A - Search Results

1

[Conventional and experimental prognostic factors in ovarian cancer].

Sehouli J, Mustea A, Könsgen D, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Zentralbl Gynakol. 2004 Oct;126(5):315-22. doi: 10.1055/s-2004-832305. Zentralbl Gynakol. 2004. PMID: 15478050 Review. German.

2

["IMO"--intraoperative mapping of ovarian cancer].

Sehouli J, Könsgen D, Mustea A, Oskay-Ozcelik G, Katsares I, Weidemann H, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Zentralbl Gynakol. 2003 Mar-Apr;125(3-4):129-35. doi: 10.1055/s-2003-41864. Zentralbl Gynakol. 2003. PMID: 12961105 German.

3

[Role of PAI-1 in gynaecological malignancies].

Könsgen D, Mustea A, Lichtenegger W, Sehouli J. Könsgen D, et al. Among authors: mustea a. Zentralbl Gynakol. 2005 Jun;127(3):125-31. doi: 10.1055/s-2005-836407. Zentralbl Gynakol. 2005. PMID: 15915389 Review. German.

4

Overexpression of the plasminogen activator inhibitor type-1 in epithelial ovarian cancer.

Koensgen D, Mustea A, Denkert C, Sun PM, Lichtenegger W, Sehouli J. Koensgen D, et al. Among authors: mustea a. Anticancer Res. 2006 Mar-Apr;26(2C):1683-9. Anticancer Res. 2006. PMID: 16617562 Free article.

5

Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer.

Sehouli J, Mustea A, Koensgen D, Chen FC, Lichtenegger W. Sehouli J, et al. Among authors: mustea a. Ann Oncol. 2003 Oct;14(10):1501-4. doi: 10.1093/annonc/mdg413. Ann Oncol. 2003. PMID: 14504049 Free article.

6

Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in Germany.

Chekerov R, Denkert C, Boehmer D, Suesse A, Widing A, Ruhmland B, Giese A, Mustea A, Lichtenegger W, Sehouli J. Chekerov R, et al. Among authors: mustea a. Int J Gynecol Cancer. 2008 Jan-Feb;18(1):1-7. doi: 10.1111/j.1525-1438.2007.00971.x. Epub 2007 Apr 27. Int J Gynecol Cancer. 2008. PMID: 17466034

7

Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.

Mustea A, Pirvulescu C, Könsgen D, Braicu EI, Yuan S, Sun P, Lichtenegger W, Sehouli J. Mustea A, et al. Cytokine. 2008 Apr;42(1):77-84. doi: 10.1016/j.cyto.2008.01.011. Epub 2008 Mar 7. Cytokine. 2008. PMID: 18329282

8

Detection of epithelial carcinoma cells in the blood of patients with gynaecological malignancies.

Sehouli J, Könsgen D, Nimpsch R, Oskay G, Stengel D, Oertel J, Lichtenegger W, Mustea A. Sehouli J, et al. Among authors: mustea a. Anticancer Res. 2003 Mar-Apr;23(2A):1093-7. Anticancer Res. 2003. PMID: 12820353

9

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.

Harter P, Sehouli J, Vergote I, Ferron G, Reuss A, Meier W, Greggi S, Mosgaard BJ, Selle F, Guyon F, Pomel C, Lécuru F, Zang R, Avall-Lundqvist E, Kim JW, Ponce J, Raspagliesi F, Kristensen G, Classe JM, Hillemanns P, Jensen P, Hasenburg A, Ghaem-Maghami S, Mirza MR, Lund B, Reinthaller A, Santaballa A, Olaitan A, Hilpert F, du Bois A; DESKTOP III Investigators. Harter P, et al. N Engl J Med. 2021 Dec 2;385(23):2123-2131. doi: 10.1056/NEJMoa2103294. N Engl J Med. 2021. PMID: 34874631 Clinical Trial.

10

Polymorphism of the IL-8 gene and the risk of ovarian cancer.

Koensgen D, Bruennert D, Ungureanu S, Sofroni D, Braicu EI, Sehouli J, Sümnig A, Delogu S, Zygmunt M, Goyal P, Evert M, Olek S, Biebler KE, Mustea A. Koensgen D, et al. Among authors: mustea a. Cytokine. 2015 Feb;71(2):334-8. doi: 10.1016/j.cyto.2014.07.254. Epub 2014 Aug 21. Cytokine. 2015. PMID: 25151495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page